Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.

Autor: Coutts, Shelagh B1,2,3,4 (AUTHOR) scoutts@ucalgary.ca, Ankolekar, Sandeep5 (AUTHOR), Appireddy, Ramana6 (AUTHOR), Arenillas, Juan F7,8 (AUTHOR), Assis, Zarina9,10 (AUTHOR), Bailey, Peter11 (AUTHOR), Barber, Philip A1 (AUTHOR), Bazan, Rodrigo12 (AUTHOR), Buck, Brian H13 (AUTHOR), Butcher, Ken S14 (AUTHOR), Camden, Marie-Christine15 (AUTHOR), Campbell, Bruce C V16 (AUTHOR), Casaubon, Leanne K17 (AUTHOR), Catanese, Luciana18 (AUTHOR), Chatterjee, Kausik19 (AUTHOR), Choi, Philip M C20,21 (AUTHOR), Clarke, Brian22 (AUTHOR), Dowlatshahi, Dar23,24 (AUTHOR), Ferrari, Julia25 (AUTHOR), Field, Thalia S26 (AUTHOR)
Zdroj: Lancet. Jun2024, Vol. 403 Issue 10444, p2597-2605. 9p.
Databáze: Academic Search Ultimate